Top Markets
#1 Akedo Akedo +89.15%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.04%
#4 Cross Cross +45.95%
#5 Black Phoenix Black Phoenix +34.04%
#6 Velvet Velvet +33.27%
#7 OVERTAKE OVERTAKE +20.49%
#8 Illuvium Illuvium +18.60%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.91%
#10 Cap Cap +15.95%
Coin of the day
Akedo Akedo
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Hisse Senetlerindeki Sıralama #39102
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Hisse Fiyatı
$0.02243487
Son senkronizasyon: 2025-06-04
Piyasa Değeri
$650.09K
Değişim (1 gün)
0.39%
Değişim (1 yıl)
0.00%
Ülke
SE
Ticaret Lipidor AB (publ) (LIPI)

Kategori

Healthcare
Lipidor AB (publ) (LIPI) için gelir
Dec 2024 itibarıyla gelir TTM: $265.61K
Lipidor AB (publ) şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $265.61K'dir. 2023 yılında şirketin geliri $7.73K önceki yıla göre artış 2022 yılındaki $4.32K gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Lipidor AB (publ) için 2016 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
2026 (TTM) $265.61K 20,825.07%
2024 $1.27K -83.58%
2023 $7.73K 79.16%
2022 $4.32K -99.75%
2021 $1.70M 2,164.63%
2020 $75.02K 872.70%
2019 $7.71K -71.64%
2018 $27.20K -32.61%
2017 $40.36K 30.11%
2016 $31.02K 0.00%
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B 29,992,925.40%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B 36,868,756.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B 24,240,300.94%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B 29,184,513.78%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B 24,998,542.91%
US